Coinbase
COIN
Tesla
TSLA
Strategy
MSTR
Salesforce
CRM
Meta Platforms
META
US Stock MarketDetailed Quotes
AHCO AdaptHealth
- 10.270
- -0.190-1.82%
Trading Mar 11 11:53 ET
1.39BMarket Cap16.84P/E (TTM)
10.470High10.110Low343.20KVolume10.390Open10.460Pre Close3.52MTurnover0.39%Turnover Ratio16.84P/E (Static)134.87MShares11.90052wk High0.88P/B899.29MFloat Cap8.35052wk Low--Dividend TTM87.56MShs Float41.579Historical High--Div YieldTTM3.44%Amplitude6.370Historical Low10.242Avg Price1Lot Size
AdaptHealth Stock Forum
Sign in to post a comment
Morning Movers
Gapping Up
$EverQuote (EVER.US)$ shares surged 26% after Q4 earnings beat expectations: GAAP EPS reached $0.33 (up by $0.13) and revenue jumped 165% Y/Y to $147.45M. Q1 2025 guidance projects $155–$160M revenue, with robust growth in marketing spend and adjusted EBITDA reinforcing momentum.
$Li Auto (LI.US)$ shares jumped 13% premarket after the company unveiled its first electric SUV, the Li i8. The model quickly be...
Gapping Up
$EverQuote (EVER.US)$ shares surged 26% after Q4 earnings beat expectations: GAAP EPS reached $0.33 (up by $0.13) and revenue jumped 165% Y/Y to $147.45M. Q1 2025 guidance projects $155–$160M revenue, with robust growth in marketing spend and adjusted EBITDA reinforcing momentum.
$Li Auto (LI.US)$ shares jumped 13% premarket after the company unveiled its first electric SUV, the Li i8. The model quickly be...
23
2
7
$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
7
1
Despite promising growth forecasts, the company's P/S ratio is lower than expected due to major risk factors. The market shows hesitation about the company, despite high growth forecasted.
AdaptHealth's sales haven't grown significantly despite reinvestment into growth, causing investor concern. Their inconsistent high-growth stock traits suggest better returns elsewhere. The stock drop implies uncertain investor sentiment regarding the firm's future.
Insiders' net selling over the past year clouds the positive signal of high insider ownership levels, calling for investor caution due to associated risks.
Gainers:
In reaction to earnings/guidance:
• $GoodRx (GDRX.US)$ +38.5%, $EDGIO (EGIO.US)$ +13.5%, $Lemonade (LMND.US)$ +10.7%, $Desktop Metal (DM.US)$ +8.5%, $ShockWave Medical (SWAV.US)$ +8.2%, $Pubmatic (PUBM.US)$ +8.1%, $Olaplex (OLPX.US)$ +7%, $Vivid Seats (SEAT.US)$ +6.4%, $Noble (NE.US)$ +6.3%, $Aspen Technology (AZPN.US)$ +5.4%, $AAON Inc (AAON.US)$ +5%, $Hudbay Minerals (HBM.US)$ +5%, $Vivint Smart Home (VVNT.US)$ +4.9%, $Vivint Smart Home (VVNT.US)$ +4...
In reaction to earnings/guidance:
• $GoodRx (GDRX.US)$ +38.5%, $EDGIO (EGIO.US)$ +13.5%, $Lemonade (LMND.US)$ +10.7%, $Desktop Metal (DM.US)$ +8.5%, $ShockWave Medical (SWAV.US)$ +8.2%, $Pubmatic (PUBM.US)$ +8.1%, $Olaplex (OLPX.US)$ +7%, $Vivid Seats (SEAT.US)$ +6.4%, $Noble (NE.US)$ +6.3%, $Aspen Technology (AZPN.US)$ +5.4%, $AAON Inc (AAON.US)$ +5%, $Hudbay Minerals (HBM.US)$ +5%, $Vivint Smart Home (VVNT.US)$ +4.9%, $Vivint Smart Home (VVNT.US)$ +4...
24
11
No comment yet
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Do re mi : reliable or not? it always reverse from the news
Chris Ivan Ang : i believe that MDLZ deserves the upgrade